Our research
Thanks to our blood cancer community, we've invested over £500 million into research since 1960. Our discoveries have led to better and kinder treatments, and transformed lives.
What we do and why it matters
Funding research is at the heart of what we do, made possible solely because of our community's generosity.
Our funding has supported many advances in therapies for blood cancer, including the development of new drugs for chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), antibody treatments for lymphoma.
New classes of therapies are being developed all the time. There are huge opportunities to develop new therapies that improve and save the lives of everyone with blood cancer.
Our impact from 1960 to today
Get an overview of our research discoveries over the years and what advancements they've led to for people affected by blood cancer.
Our research projects
Explore our current research portfolio of over 90 projects spanning many types of blood cancer and different forms of research.
Our new research strategy
Our new research strategy for the next five years focuses on prevention, early detection and predicting outcomes, and treatment. It's the beginning of the future for blood cancer research.
65 years of impact
Our latest impact report highlights the progress we have made over the past 65 years: how it's transformed lives and how it's brought us closer to the day where no one dies of blood cancer or its treatments.
Our impact in numbers
We've invested over £500 million in research in the last 65 years. This has led to countless new treatments and has transformed the lives of people with blood cancer.
-
£500 million Invested into blood cancer research
-
2300+ Over 2300 research projects
-
£65 million+ Invested in studentships and fellowships
-
£35 million Invested into clinical trials
For researchers
Discover our open calls and application guidance. We offer grants for a range of research, from discovery to clinical research - plus support for early career researchers through our fellowship scheme.
"So many people behind the scenes have made this happen, people in their labs, like Professor Waseem. Alyssa wouldn't be here today without Blood Cancer UK…because there was nothing else out there except for this clinical trial. It does make a difference. It makes a huge difference."
Latest research news
Discover the real-time impact that our research is having by reading our latest news.
New study shows combination treatment could improve treatment for people with relapsed myeloma
New study strengthens evidence for new CAR T-cell treatment for aggressive blood cancer
New trial shows early signs that ‘off-the-shelf’ CAR T-cell therapy could transform treatment of myeloma
UK Blood Cancer Research Network
A multidisciplinary, supportive leadership group, setting and driving the UK blood cancer research agenda.
Why we fund research
We want to ensure the 40,000 people diagnosed with blood cancer in the UK each year are given effective treatments. We've invested over £500 million in research.
Our research projects
Our researchers are making discoveries that have a life-changing impact on people with blood cancer.
News and blogs
Latest news on blood cancer research and stories from our community.